rs150882728
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_133496.5(SLC30A7):c.663G>A(p.Pro221Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,611,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000022 ( 0 hom. )
Consequence
SLC30A7
NM_133496.5 synonymous
NM_133496.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.178
Genes affected
SLC30A7 (HGNC:19306): (solute carrier family 30 member 7) Zinc functions as a cofactor for numerous enzymes, nuclear factors, and hormones and as an intra- and intercellular signal ion. Members of the zinc transporter (ZNT)/SLC30 subfamily of the cation diffusion facilitator family, such as SLC30A7, permit cellular efflux of zinc (Seve et al., 2004 [PubMed 15154973]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 1-100918084-G-A is Benign according to our data. Variant chr1-100918084-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1624871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.178 with no splicing effect.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC30A7 | ENST00000357650.9 | c.663G>A | p.Pro221Pro | synonymous_variant | Exon 7 of 11 | 1 | NM_133496.5 | ENSP00000350278.4 | ||
SLC30A7 | ENST00000370112.8 | c.663G>A | p.Pro221Pro | synonymous_variant | Exon 7 of 12 | 1 | ENSP00000359130.4 | |||
SLC30A7 | ENST00000850622.1 | n.663G>A | non_coding_transcript_exon_variant | Exon 7 of 13 | ENSP00000520907.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152100Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250882 AF XY: 0.0000442 show subpopulations
GnomAD2 exomes
AF:
AC:
9
AN:
250882
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459338Hom.: 0 Cov.: 29 AF XY: 0.0000275 AC XY: 20AN XY: 726046 show subpopulations
GnomAD4 exome
AF:
AC:
32
AN:
1459338
Hom.:
Cov.:
29
AF XY:
AC XY:
20
AN XY:
726046
show subpopulations
African (AFR)
AF:
AC:
7
AN:
33412
American (AMR)
AF:
AC:
2
AN:
44592
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26070
East Asian (EAS)
AF:
AC:
1
AN:
39578
South Asian (SAS)
AF:
AC:
4
AN:
85954
European-Finnish (FIN)
AF:
AC:
1
AN:
53328
Middle Eastern (MID)
AF:
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
AC:
12
AN:
1110358
Other (OTH)
AF:
AC:
5
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.434
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
6
AN:
152218
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41536
American (AMR)
AF:
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68000
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...